google-site-verification: googlec7193c3de77668c9.html

Study tracks early adoption of liver histotripsy treatment

[
It has been nearly three years since the U.S. Food and Drug Administration (FDA) cleared the HistoSonics Edison histotripsy system to treat primary and metastatic liver tumors. To examine how the technology’s adoption and use have progressed, a research team at the University of Virginia, led by Allan Tsung, M.D., professor and chair of the Department of Surgery, sought to provide an early national snapshot of its use for this indication.


Source link

Advertisements

See also  Body's own cell-to-cell messaging packets studied as the basis for next-generation medicines

Check Also

Choline supplementation in young children with fetal alcohol spectrum disorder can have durable developmental benefits

[ Credit: Unsplash/CC0 Public Domain Children affected by prenatal alcohol exposure (PAE) experience long-lasting cognitive …

Changes in marital status may heighten vulnerability for alcohol-related problems

[ Credit: Aakash Goel from Pexels People who have experienced mixed marital transitions or who …

The Fix

Two former addicts run a church in Burnley trying to help people in crisis. BBC …

Leave a Reply

Available for Amazon Prime